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Abstract 
Background: Glycosylation is one of the most abundant posttranslational polypeptide chain modification in nature. 
Although carbohydrate modification of protein antigens from many microbial pathogens constitutes important com-
ponents of B cell epitopes, the role in T cell immunity is not completely understood. There is growing evidence about 
the importance of these modifications in host bacteria interactions in tuberculosis. It is known, that the sugars present 
in some Mycobacterium tuberculosis glycoproteins play an important role in both humoral and cellular immune 
response against the pathogen. Since this modification is lost in the recombinant proteins expressed in Escherichia 
coli, it is fundamental to search for host bacteria with the capacity to modify the foreign proteins. Amongst the bacte-
ria that are likely to have this possibility are some members of Rhodococcus genus which are Gram-positive bacteria, 
with high GC-content and genetically very close related to M. tuberculosis.
Results: In this work, apa, pstS1 and lprG genes that coding for M. tuberculosis glycoproteins were cloned and 
expressed in Rhodococcus erythropolis. All recombinant proteins were mannosylated as demonstrated by their interac-
tion with mannose binding lectin Concanavalin A. In addition, as native proteins recombinants Apa and PstS1 were 
secreted to the culture medium in contrast with LprG that was retained in the cell wall.
Conclusions: Together these results, point out R. erythropolis, as a new host for expression of M. tuberculosis 
glycoproteins.
Keywords: Rhodococcus erythropolis, Recombinant glycoproteins, Posttranslational modification, Mycobacterium 
tuberculosis
© The Author(s) 2017. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
According to Worth Health Organization, tuberculosis 
claims about 2 million lives every year with almost one-
third of the human population infected with M. tuber-
culosis, a microorganism that develops resistance to 
virtually all new drugs produced to fight it. Inadequate 
dosing and incomplete treatment regimens, together 
with the ability of the bacilli to cause latent infections 
that are tolerant of currently used drugs, have con-
tributed to the rise of multidrug-resistant tuberculosis 
[1]. While intensive research efforts are addressing the 
pathogenesis, new drugs and vaccines are also necessary 
to explore into conceptual novel approaches for tubercu-
losis control. Studies of the role of M. tuberculosis mol-
ecules involved in host bacteria interactions identified 
a number of immunodominant mycobacterial proteins 
which undergo a process of posttranslational modifica-
tions such as glycosylation, lipoylation and methylation 
that provide important immunological properties [2–7]. 
Thus, these proteins are leading candidates for vaccine 
development. However, progress in this field has been 
hampered by the unavailability to obtain large quantities 
of recombinant modified extracellular proteins. At date, 
only a few M. tuberculosis proteins with posttranslational 
modifications have been expressed in Mycobacterium 
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smegmatis and Streptomyces lividans since the recombi-
nant proteins obtained in E. coli cannot be modified [2, 
8–10].
Based on the high percentages of homology detected 
between putative lipoglycoproteins of M. tuberculo-
sis and Rhodococcus spp. RHA1 as well as with a key 
enzyme for O-mannosylation, the O-mannosyl trans-
ferase, we envisioned Rhodococcus spp. as a candidate 
for expression of M. tuberculosis recombinant glycopro-
teins [7]. Rhodococcus spp. is a GC-high content bac-
terium, which metabolizes a wide range of compounds 
and represents a genus of considerable industrial interest 
[11]. In the present work, we investigated the feasibility 
of R. erythropolis as a host for the recombinant produc-
tion of M. tuberculosis glycoproteins, Apa and the lipo-
glycoproteins PstS1 and LprG. All these proteins interact 
with molecules of innate immune system and play an 
important role in the induction of both cellular and 
antibody responses against M. tuberculosis. Apa is an 
Alanine/Proline rich antigen of 45/47 kDa and a potent 
inductor of T cell immune response which dependent of 
the O-mannosylation status [2, 3]. This protein together 
with PstS1 was the first glycoprotein described in M. 
tuberculosis [12]. PstS1 a 38 kDa is an immunodominant 
mannosylated lipoprotein (Lpp) and is also a phosphate 
transporter [13–15]. Disruption of pstS1 gene reduces 
the in  vivo multiplication of M. tuberculosis [16]. LprG 
a 27 kDa mannosylated Lpp, was found in the cell mem-
brane of M. tuberculosis and Mycobacterium bovis [17, 
18]. This protein is considered a virulence factor, since 
a knockout of lprG gene has proved to be attenuated in 
virulence in a mouse tuberculosis model [19]. In addi-
tion, all the proteins mentioned above, interact with the 
host through their glycan structures. Both Apa and LprG 
are ligands for macrophage and dendritic cell-specific 
intercellular adhesion molecule-3-grabbing non-integrin 
(DC-SIGN) [3, 20, 21] and Apa and PstS1 interact with 
macrophage mannose receptor (MR) [3, 22,]. Apa also 
binds to the pulmonary surfactant protein A, a member 
of C-type lectins from the innate immune system, this 
interaction is calcium- and mannose-dependent. Indeed 
all these molecules; DC_SIGN, MR and surfactant pro-
tein A have been shown to bind mycobacteria and facili-
tate their entry into phagocytes [20–23]. LprG and PstS1 
interact with Toll-like receptors (TLR); however while 
the interaction of PstS1 through both TLR-2 and TLR-4 
induces the activation of pathways, which play an essen-
tial role in tumor necrosis factor alpha (TNF-α) and 
interleukine 6 (IL-6) expression during mycobacterial 
infection [24], the interaction of LprG with TLR-2 inhib-
its Major histocompatibility complex class II antigen 
processing in human macrophages [25]. More recently, it 
was found that carbohydrate moieties were required for 
activation of TLR-2 by LprG to stimulate or inhibit T cell 
activation [3].
Because of the importance of M. tuberculosis antigens 
posttransduccionally modified, the availability of het-
erologous expression systems is a tool that will allow a 
deeper understanding of the role these proteins play in 
the pathogenesis of the disease.
Methods
Bacterial strains and culture conditions
Escherichia coli TOP10F′ (Invitrogen, USA) used for 
cloning was grown in Luria-Bertani broth (LB) (Difco, 
MI, USA). R. erythropolis strain L88, a lysozyme sensible 
mutant was grown to 26 °C in the same culture medium 
used for E coli. This bacterium was used as a host for 
recombinants thiostrepton induced (pTip-QC1) and con-
stitutive (pNit-QC1) plasmids [26–28].
Cloning of M. tuberculosis apa, pstS1, and lprG codificant 
sequences in R. erythropolis
The complete coding regions of the apa, pstS1 and lprG 
were amplified by PCR with the high fidelity DNA pol-
ymerase Pfx (Invitrogen) from M. tuberculosis H37Rv 
genomic DNA with the following oligonucleotide primers: 
ApaRhoFo: 5′-CATCAGGTGGACCCCAACTTGAC-3′ 
and ApaRhoRv, 5′-GAGGATCCGGCCGGTAAGGTCC 
GCTGC-3′ (BamHI site in bold); PstS1RhoFo: 5′-AAAA 
TTCGTTTGCATACGCTGTTGG-3′ and PstS1RhoRv5′-
GAGGATCCGCTGGAAATCGTCGCGATCAAC-3′ 
(BamHI site in bold); LprGRhoFo: 5′-CGGACCCCCAGA 
CGCCAC-3′ and LprGRhoRv: 5′-GCAAGATCTGCTC 
ACCGGGGGCTTCGTG-3′ (BglII site in bold). PCR 
products, apa (980 bp), pstS1 (1127 bp) and lprG (714 bp) 
were cloned into the pTip-QC1 and pNit-QC1 vectors as 
follow: plasmids were digested with NcoI, 5′ NcoI over-
hangs were filled using T4 DNA polymerase (Thermo 
Scientific, USA) then, plasmids were digested with BglII 
and gel purified. Purified PCR product of apa and pstS1 
ware digested with BamHI and cloned into the vectors to 
generate pTip-QC1-apa and pNit-QC1-apa; pTip-QC1-
pstS1 and pNit-QC1-pstS1 respectively. PCR product of 
lprG was digested with BglII and ligated into the vectors 
to generate pTip-QC1-lprG and pNit-QC1-lprG. The 
identities and orientation of the inserts were confirmed 
by restriction analysis and DNA-sequencing. All the 
recombinant plasmids purified from E. coli were used to 
transform R. erythropolis L88 strain by electroporation as 
described elsewhere for mycobacteria [29]. Transformed 
cells were selected in LB agar plates supplemented with 
34  μg/ml of chloramphenicol (Chl) and incubated at 
26 °C.
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Expression and purification Apa, PstS1 and LprG C‑terminal 
Hexahistidine‑tagged proteins in R. erythropolis
A single R. erythropolis recombinant colony obtained 
of each pTip-QC1 and pNit-QC1 derivated vectors was 
grown overnight (ON) in 5 ml of LB broth supplemented 
with 34 μg/ml of Chl (LB-Chl) at 26  °C and 200 revolu-
tion per minute (rpm). The next day, small-scale expres-
sions of recombinant Apa (rRhoApa), PstS1 (rRhoPstS1) 
and LprG (rRhoLprG) were performed by diluted ON 
cultures 1:100 in 50 ml of LB-chl. Cells transformed with 
constitutive pNit-QC1 recombinant vector were grown 
for 48 h at 26 °C at 200 rpm. Expression of recombinant 
proteins in cells transformed with pTip-QC1 vectors, 
were induced with 1  μg/ml of thiostrepton (Sigma) at 
24 h of culture and then bacteria were grown for 24 more 
hours.
Cells were harvested by centrifugation at 3500×g for 
15 min at 4 °C. Cell pellet was resuspended in lysis buffer 
(50  mM Tris–HCl, 50  mM NaCl, 1  mM DDT, pH 8.0), 
and bacteria was disrupted by sonication on ice during 
15 min with cycles of 1 min and 1 min rest at 15–20% of 
potency in a Virsonic 550 sonicator (VirTis). After that, 
sample was centrifuged at 11000×g for 15 min at 4 °C to 
obtain the soluble extract (SE) and the insoluble fraction 
(IF). This fraction, was then washed twice with 1% Triton 
X-100 in phosphate buffered saline (PBS) and once only 
with PBS. After that, sample was solubilized in sample 
buffer (10 mM Tris–HCl, 50 mM NaCl, 5 mM imidazol, 
pH 8.0) with 8 M of urea and the mixture was stirred at 
room temperature (RT) for 20 min.
Cultures supernatant (CS) was precipitated with 90% 
of saturated ammonium sulphate solution at 4  °C, pro-
teins were collected by centrifugation at 14000×g for 
30  min at 4  °C. Obtained pellets were re-suspended in 
PBS and dialyzed against this same buffer for elimina-
tion of ammonium sulphate. Presence of recombinant 
proteins in the different obtained fractions was verified 
by sodium dodecyl sulfate–polyacrylamide gel electro-
phoresis (SDS-PAGE) and by Western blot assay with 
an anti-Hexahistidine Horseradish peroxidase antibody 
(anti-His6-HRP) (Roche).
rRhoApa, rRhoPstS1 and rRhoLprG were purified from 
clarified SE, IF and CS fractions using an AKTÄ Prime 
System (GE Healthcare) with 1  ml, HistrapMT column 
(GE Healthcare). For SE and CS fraction after washing 
and equilibration of Ni–NTA column with sample buffer, 
sample was loaded and then the column was washed, 
with wash buffer (50 mM Tris–HCl, 50 mM NaCl, 25 mM 
imidazol, pH 8.0). Protein was eluted with elution buffer 
(10 mM Tris–HCl, 50 mM NaCl, 500 mM imidazol, pH 
8.0) at 1 ml/min, by using a gradient (0–100% of elution 
buffer) and fractions displaying the recombinant proteins 
were pooled and dialyzed to eliminated the imidazol. In 
the case of IF, protein was purified in denaturing condi-
tion, all employed buffers contained 8 M urea and frac-
tions displaying the recombinant proteins were pooled 
and dialyzed against decreasing urea concentrations. The 
presence of purified recombinant proteins was moni-
tored by SDS-PAGE. The amount of protein was quan-
tified by the modified Lowry method and proteins were 
stored at −70 °C until needed.
Western blot assays and ligand blotting assay
Purified recombinant proteins from R. erythropolis SE, 
IF and CS fractions, were resolved on a 12% SDS-PAGE, 
transferred to a Polyvinylidene fluoride (PVDF) mem-
brane and visualized by Coomassie brilliant blue R-250 
staining. All membranes were blocked with 3% bovine 
serum albumin (BSA) in PBS at RT for 1  h. After three 
washes with PBS containing 0.05% Tween 20 (PBS-T), 
the presence of purified recombinant proteins from R. 
erythropolis cell fractions and CS were identified by 
Western blot assay with specific antibodies. Rabbit poly-
clonal antibodies raised against rRhoPstS1 and rRhoL-
prG [7] were diluted 1:500 in PBS-T and membranes 
were incubated for 1  h at RT in constant agitation. For 
specific detection of rRhoApa, membranes were incu-
bated for 1  h with anti-Apa 6A3 monoclonal antibody 
(6A3 mAb) [30], diluted 1:500 in PBS-T/BSA. After sev-
eral washes with PBS-T, membranes were incubated for 
1 h with Protein A-HRP (Zymed) diluted 1:2000 in PBS-T 
for detection of polyclonal rabbit anti-sera and with anti-
mouse IgG-HRP antibody (Invitrogen) diluted 1:2000 in 
PBS-T for detection of 6A3 mAb. Glycosylation of the 
recombinant proteins was determined by ligand blotting 
assay using the lectin Concanavalin A-HRP (Con A-HRP) 
(Sigma). Membranes were incubated with shaking ON at 
23 °C with ConA-HPR diluted 1:1000 in incubation buffer 
(1 mM NaCL, 1 mM MgCL, and 1 mM MnCL) in pres-
ence or not of 0.3  M of methyl-α-d-mannopyranoside 
(Sigma). After incubation of membranes with the indi-
cated primary and secondary antibody or ConA-HRP, 
membranes were washed with PBS-T, and developed 
with 3 mg/ml of 3,3-diaminobenzidine (DAB) (Sigma) in 
PBS with 1:1000 dilution of 30% of hydrogen peroxide.
Results
Expression and purification of rRhoApa
rRhoApa was similarly expressed from either R. eryth-
ropolis transformed with pTip-QC1-apa or pNit-QC1-
apa vectors. Histidine-tagged proteins were found in SE, 
IF and CS fractions as detected with the anti-His6-HRP 
(Data not shown).
Purification of protein was carried out by Ni–NTA 
affinity chromatography. Figure 1a, shows the Coomassie 
blue stained of purified protein from different fractions 
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obtained from R. erythropolis transformed with expres-
sion vector pNit-QC1-apa, one band of 47  kDa was 
observed in rRhoApa purified from SE and CS (Fig.  1a, 
lines 2 and 4), a double band of 48/47  kDa was seen in 
purified protein from IF that could correspond to unpro-
cessed and mature protein (Fig. 1a, line 3). All the puri-
fied proteins were recognized as a unique and well defined 
bands by Con A in ligand blotting assay (Fig.  1b) or in 
Western blot with the 6A3 mAb (Fig. 1c). However, when 
the CS crude fraction and the flow through fraction from 
the Ni–NTA column were incubated with 6A3 mAb, 
a double band of 45/47  kDa was detected (Fig.  1d, lines 
1 and 2) in contrast with ConA or anti-His6-HRP which 
only detect the higher molecular mass band (Not shown).
Expression and purification of rRhoPstS1
rRhoPstS1 was not expressed from R. erythropolis trans-
formed with induced vector pTip-QC1-pstS1. Recombi-
nant proteins obtained from bacteria transformed with 
constitutive pNit-QC1-pstS1 vector were identified in SE, 
IF and CS fractions with anti-His6-HRP (Data not shown).
Figure  2a, shows the Coomassie blue stained of puri-
fied protein from the different fractions obtained from 
R. erythropolis transformed with expression vector pNit-
QC1-pstS1. As native protein rRhoPstS1 was found in 
CS fractions. Two bands were observed in protein puri-
fied from IF, that could correspond to unprocessed and 
mature protein (Fig. 2a, line 4). Purified rRhoPstS1 from 
different fractions was recognized by Con A (Fig.  2b) 
and by rabbit polyclonal antibody raised against E. coli 
recombinant PstS1 (rE.coliPstS1) (Fig. 2c).
Expression and purification of M. tuberculosis rRhoLprG
rRhoLprG was similar expressed from either R. erythro-
polis transformed with pTip-QC1 or pNit-QC1 vectors 
(Results not shown). Proteins were detected with anti-
His6-HRP in SE and IF but not in the CS (Not shown). 
In Fig.  3a, the Coomassie blue stained of purified pro-
teins obtained from the different fractions is shown. Two 
bands were observed in protein purified from IF, that 
could correspond to unprocessed and mature protein 
(Fig.  3a, line 3). Both purified proteins from SE and IF 
were recognized by Con A (Fig. 3b) and by rabbit poly-
clonal antibody raised against E. coli recombinant LprG 
(rE.coliLprG) (Fig. 3c).
Yields of purified proteins
Similar yields of purified recombinant proteins were 
obtained from SE and IF of rRhoApa and rRhoPstS1, 
in contrast with the lower amount obtained from CS of 
rRhoPstS1. Similar yields were also obtained with bac-
teria transformed with either pTip-QC1-apa or pNit-
QC1-apa and the same was seen for pTip-QC1-lprG 
or pNit-QC1-lprG but with a very lower production of 
proteins from SE and IF proteins and not expression at 
all of rRhoLprG, protein from CS. rRhoPstS1 was not 
expressed from bacteria transformed with inducible 
pTip-QC1-pstS1 vector. The yields of proteins are the 
average of 3 experiments (Table 1).
Discussion
In this work, the coding regions corresponding to imma-
ture mycobacterial glycoproteins were amplified from M. 
tuberculosis H37Rv genomic DNA and cloned in both R. 
erythropolis pNit-QC1 (constitutive) and pTip-QC1 (thi-
ostrepton inducible) expression vectors. The positive sig-
nal obtained with Con A in ligand blotting assays showed 
that Apa, PstS1and LprG the studied proteins were man-
nosylated, confirming this result that R. erythropolis pos-
sess the machinery to mannosylate proteins from M. 
Fig. 1 Analyses of purified rRhoApa from R. erythropolis transformed pNit-QC1-apa vector. a M. tuberculosis CS crude fraction and recombinant puri-
fied proteins blotted to PVDF membrane stained with Coomassie blue. Lane 1, M. tuberculosis H37Rv CS crude fraction. Line 2, purified protein from 
SE. Line 3, purified protein from IF. Line 4, purified protein from CS. Line 5, rE. coli Apa. b, c Lines are the same as a, but proteins were detected with 
Con A-HRP and with 6A3 mAb respectively. d Line 1, CS crude fraction from recombinant R. erythropolis and line 2, the flow through fraction from 
Ni-NTA column, both were detected with 6A3 mAb. Protein size markers are indicating on the left
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tuberculosis. Although these proteins had been expressed 
in different host: all of them in E. coli [2, 7], PstS1 in M. 
smegmatis [8] and Apa in M. smegmatis and M. bovis 
BCG [2, 31], yields had been only reported for Apa pro-
duced in S. lividans. Vallin et  al. [32] obtained 80  mg/l 
of purified rApa from CS and Gamboa-Suasnavart et al. 
[33] reported a higher production of CS rApa in coiled 
and in baffled flasks 7.44 ± 0.15 g/l than in conventional 
flasks 4.02  ±  0.08  g/l. From these results is clear that 
the production of rRhoApa from CS is lower that rApa 
obtained from CS of S. lividans. The evaluation of both 
recombinant proteins in a tuberculosis animal model will 
be important to define their antigenic and immunogenic 
potential.
Among the M. tuberculosis glycoproteins, Apa has been 
one of the most studied; this molecule is secreted to the 
culture medium as a double band of 47/45 kDa, through 
double Arginine translocase exportation system [34]. 
Their glycosylation sites determined by Dobos et al. [35] 
were located in Threonine (T), T10, T18 and T27 in N-ter-
minus and in T277 in C-terminus. Furthermore, stud-
ies by Horn et al. [2] suggested that Apa double band is 
the result of proteolytic cleavage of the protein between 
Proline275 and T276, the calculated mass of the fragment 
devoid of mannose was 27,616 Da and could correspond 
to the C-terminal truncated peptide (1–275). Purified 
rRhoApa from CS was found as a unique band; however 
when the CS crude extract was incubated with 6A3 mAb, 
two bands of 47/45 kDa were seen. An explanation is that 
Apa could being processes in the C-terminus and due 
to the loss of the Hexahistidine-tag, only one band was 
purified. The not reactivity of the lower band with Con 
Fig. 2 Analyses of purified rRhoPstS1 from R. erythropolis transformed with pNit-QC1-psts1 vector. a M. tuberculosis CS crude fraction and recom-
binant purified proteins blotted to PVDF membrane stained with Coomassie blue. Lane 1, M. tuberculosis CS crude fraction. Lane 2, purified protein 
from SE. Line 3, purified protein from IF. Line 4, rE.coliPstS1. b, c Lines are the same as a, but proteins were detected with Con A-HRP and with rabbit 
polyclonal antibody raised against rE.coliPstS1. Protein size markers are indicating on the left
Fig. 3 Analyses of purified rRhoLprG from R. erythropolis transformed pNit-QC1-lprG vector. a M. tuberculosis CS crude fraction and recombinant 
purified proteins blotted to PVDF membrane stained with Coomassie blue. Lane 1, M. tuberculosis CS crude fraction. Line 2, purified protein from 
SE. Line 3, purified protein from IF. Line 4, rE. coliLprG. b, c: Lines are the same as a, but proteins were detected with Con A-HRP (a) and with a rabbit 
polyclonal antibody raised against rE.coliLprG (b). Protein size markers are indicating on the left
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A in CS crude extract could be due to changes in glyco-
sylation pattern as was observed from Apa recombinant 
expressed in S. lividans [7].
Both PstS1 and LprG are Lpp which are predicted to be 
localized on the cell wall, through their acyl chains. The 
N-terminal signal sequence of these molecules is distin-
guishable by the presence of a lipobox motif that includes 
an invariant Cysteine at the −1 position of the cleaved 
mature protein. However, as native, rRhoPstS1 was found 
in CS [7]. It is possible that as has been described for 
some Lpp of Bacillus subtilis, mycobacterial Lpp being 
consistently released from membrane through a pro-
teolytic “shaving”. The most important determinant for 
Lpp release in B. subtilis seems to be on Glycine2 (G) 
position of the mature Lpp, whereas a Serine (S) on this 
position seems more important for membrane retention 
[36]. Interestingly, N-terminal sequence of native PstS1 
released to CS showed a cleavage site between G1 and 
S2 position of the cleaved mature protein (Unpublished 
data).
It is worth of mention, that in addition to be very close 
genetically related to M. tuberculosis [11], Rhodococ-
cus spp. in contrast with other actinomycetes have some 
advantages for expression of heterologous proteins such 
as: recombinant proteins are not affected by proteases 
activity and because the bacteria do not undergo a cel-
lular differentiation, they grow very well in standard LB 
medium.
The importance of mannosylation in M. tuberculosis 
proteins is growing, and the role of glycans in host-path-
ogen interaction as well as the modulation of the immune 
response made them as important targets in the fight 
against tuberculosis.
Conclusions
Results obtained concerning heterologous production 
of recombinant M. tuberculosis glycoproteins, demon-
strated the potential of R. erythropolis as a valuable host 
for the production of recombinant proteins from M. 
tuberculosis.
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